These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 7778957

  • 1. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
    Ramirez JA, Srinath L, Ahkee S, Huang A, Raff MJ.
    Arch Intern Med; 1995 Jun 26; 155(12):1273-6. PubMed ID: 7778957
    [Abstract] [Full Text] [Related]

  • 2. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
    Fernández P, San Martín L.
    Rev Med Chil; 2000 Mar 26; 128(3):267-72. PubMed ID: 10962867
    [Abstract] [Full Text] [Related]

  • 3. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T, Petermann W, Schürmann D, Bauer TT, Reimnitz P, MOXIRAPID Study Group.
    Clin Infect Dis; 2005 Dec 15; 41(12):1697-705. PubMed ID: 16288390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M, Chevalier I, Sterescu A, Bergeron S, Brunet S, Taddeo D.
    Pediatrics; 2004 Oct 15; 114(4):e469-76. PubMed ID: 15466073
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacoeconomic considerations associated with the use of intravenous-to-oral moxifloxacin for community-acquired pneumonia.
    Davis SL, Delgado G, McKinnon PS.
    Clin Infect Dis; 2005 Jul 15; 41 Suppl 2():S136-43. PubMed ID: 15942880
    [Abstract] [Full Text] [Related]

  • 10. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW, Lindstrom ST.
    Respirology; 2007 Jan 15; 12(1):111-6. PubMed ID: 17207035
    [Abstract] [Full Text] [Related]

  • 11. Causes and risk factors for rehospitalization of patients hospitalized with community-acquired pneumonia.
    Jasti H, Mortensen EM, Obrosky DS, Kapoor WN, Fine MJ.
    Clin Infect Dis; 2008 Feb 15; 46(4):550-6. PubMed ID: 18194099
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A, Garau J, Arvis P, Carlet J, Choudhri S, Kureishi A, Le Berre MA, Lode H, Winter J, Read RC, MOTIV (MOxifloxacin Treatment IV) Study Group.
    Clin Infect Dis; 2008 May 15; 46(10):1499-509. PubMed ID: 18419482
    [Abstract] [Full Text] [Related]

  • 14. Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.
    Pertel PE, Bernardo P, Fogarty C, Matthews P, Northland R, Benvenuto M, Thorne GM, Luperchio SA, Arbeit RD, Alder J.
    Clin Infect Dis; 2008 Apr 15; 46(8):1142-51. PubMed ID: 18444848
    [Abstract] [Full Text] [Related]

  • 15. How short can courses be in lower respiratory tract infections?
    Siegel R.
    J Int Med Res; 2000 Apr 15; 28 Suppl 1():37A-47A. PubMed ID: 11092228
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
    Cassiere HA, Fein AM.
    Semin Respir Infect; 1998 Mar 15; 13(1):36-42. PubMed ID: 9543474
    [Abstract] [Full Text] [Related]

  • 20. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
    Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.
    Curr Med Res Opin; 2008 Mar 15; 24(3):895-906. PubMed ID: 18419876
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.